Northern Trust’s Alimera Sciences ALIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-86,299
| Closed | -$480K | – | 4470 |
|
|
2024
Q2 | $480K | Buy |
86,299
+12,881
| +18% | +$45.7K | ﹤0.01% | 3528 |
|
|
2024
Q1 | $286K | Buy |
73,418
+59,286
| +420% | +$226K | ﹤0.01% | 3761 |
|
|
2023
Q4 | $61K | Buy |
+14,132
| New | +$47.7K | ﹤0.01% | 4202 |
|
|
2019
Q4 | – | Sell |
-7,440
| Closed | -$63K | – | 4307 |
|
|
2019
Q3 | $63K | Hold |
7,440
| – | – | ﹤0.01% | 4020 |
|
|
2019
Q2 | $99K | Sell |
7,440
-10
| -0.1% | -$141 | ﹤0.01% | 3975 |
|
|
2019
Q1 | $118K | Buy |
7,450
+296
| +4% | +$4.5K | ﹤0.01% | 3890 |
|
|
2018
Q4 | $77K | Hold |
7,154
| – | – | ﹤0.01% | 3975 |
|
|
2018
Q3 | $105K | Sell |
7,154
-311
| -4% | -$4.73K | ﹤0.01% | 4019 |
|
|
2018
Q2 | $109K | Hold |
7,465
| – | – | ﹤0.01% | 4002 |
|
|
2018
Q1 | $115K | Buy |
7,465
+612
| +9% | +$10.9K | ﹤0.01% | 3944 |
|
|
2017
Q4 | $137K | Hold |
6,853
| – | – | ﹤0.01% | 3911 |
|
|
2017
Q3 | $139K | Hold |
6,853
| – | – | ﹤0.01% | 3877 |
|
|
2017
Q2 | $143K | Hold |
6,853
| – | – | ﹤0.01% | 3889 |
|
|
2017
Q1 | $144K | Sell |
6,853
-243
| -3% | -$4.68K | ﹤0.01% | 3878 |
|
|
2016
Q4 | $115K | Buy |
7,096
+75
| +1% | +$1.37K | ﹤0.01% | 3875 |
|
|
2016
Q3 | $157K | Buy |
7,021
+3,660
| +109% | +$84.2K | ﹤0.01% | 3796 |
|
|
2016
Q2 | $62K | Sell |
3,361
-18,026
| -84% | -$479K | ﹤0.01% | 3981 |
|
|
2016
Q1 | $561K | Buy |
21,387
+349
| +2% | +$10.9K | ﹤0.01% | 3436 |
|
|
2015
Q4 | $764K | Buy |
21,038
+131
| +0.6% | +$5.68K | ﹤0.01% | 3394 |
|
|
2015
Q3 | $694K | Buy |
20,907
+2,979
| +17% | +$168K | ﹤0.01% | 3412 |
|
|
2015
Q2 | $1.24M | Sell |
17,928
-323
| -2% | -$22.3K | ﹤0.01% | 3260 |
|
|
2015
Q1 | $1.37M | Buy |
18,251
+37
| +0.2% | +$2.91K | ﹤0.01% | 3296 |
|
|
2014
Q4 | $1.51M | Buy |
18,214
+550
| +3% | +$44.6K | ﹤0.01% | 3248 |
|
|
2014
Q3 | $1.44M | Buy |
17,664
+3,205
| +22% | +$274K | ﹤0.01% | 3287 |
|
|
2014
Q2 | $1.3M | Buy |
14,459
+886
| +7% | +$78.7K | ﹤0.01% | 3297 |
|
|
2014
Q1 | $1.61M | Sell |
13,573
-575
| -4% | -$55.8K | ﹤0.01% | 3237 |
|
|
2013
Q4 | $997K | Buy |
14,148
+214
| +2% | +$8.72K | ﹤0.01% | 3382 |
|
|
2013
Q3 | $786K | Buy |
13,934
+9,348
| +204% | +$587K | ﹤0.01% | 3383 |
|
|
2013
Q2 | $336K | Buy |
+4,586
| New | +$265K | ﹤0.01% | 3538 |
|
Northern Trust's ALIM Position: Q3 2024 in Review
Northern Trust sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 86,299 shares — an estimated $480K sold.
Northern Trust first reported a position in ALIM in Q2 2013 and held it in 29 quarters. The position peaked at $1.61M in Q1 2014. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.
- Northern Trust reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
- Northern Trust sold 86,299 Alimera Sciences shares in Q3 2024, an estimated $480K.
- Northern Trust first reported a position in Alimera Sciences in Q2 2013 and held it in 29 quarters.
- Northern Trust's Alimera Sciences position peaked at $1.61M in Q1 2014.
- 0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.
Based on Northern Trust's 13F filing for Q3 2024, filed 13 Nov 2024.